BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27779444)

  • 1. Selective Anticancer Activity of Acacetin Against Chronic Lymphocytic Leukemia Using Both In Vivo and In Vitro Methods: Key Role of Oxidative Stress and Cancerous Mitochondria.
    Salimi A; Roudkenar MH; Sadeghi L; Mohseni A; Seydi E; Pirahmadi N; Pourahmad J
    Nutr Cancer; 2016; 68(8):1404-1416. PubMed ID: 27779444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective toxicity of persian gulf sea cucumber holothuria parva on human chronic lymphocytic leukemia b lymphocytes by direct mitochondrial targeting.
    Salimi A; Motallebi A; Ayatollahi M; Seydi E; Mohseni AR; Nazemi M; Pourahmad J
    Environ Toxicol; 2017 Apr; 32(4):1158-1169. PubMed ID: 27404045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria.
    Salimi A; Roudkenar MH; Sadeghi L; Mohseni A; Seydi E; Pirahmadi N; Pourahmad J
    Redox Biol; 2015 Dec; 6():461-471. PubMed ID: 26418626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
    Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
    Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrysin as an Anti-Cancer Agent Exerts Selective Toxicity by Directly Inhibiting Mitochondrial Complex II and V in CLL B-lymphocytes.
    Salimi A; Roudkenar MH; Seydi E; Sadeghi L; Mohseni A; Pirahmadi N; Pourahmad J
    Cancer Invest; 2017 Mar; 35(3):174-186. PubMed ID: 28301251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
    Santidrián AF; Cosialls AM; Coll-Mulet L; Iglesias-Serret D; de Frias M; González-Gironès DM; Campàs C; Domingo A; Pons G; Gil J
    Haematologica; 2007 Dec; 92(12):1631-8. PubMed ID: 18055986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iranian Mesobuthus Eupeus Crude Venom Induces Selective Toxicity in Chronic Lymphocytic Leukemia B-Lymphocytes Through Lysosomal/Mitochondrial Dysfunction and Reactive Oxygen Species Formation.
    Salimi A; Adhami V; Sajjadi Alehashem SH; Vatanpour H; Sadeghi L
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2309-2316. PubMed ID: 35901336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-lactam Structured, 4-(4-(Methylsulfonyl)phenyl)-1-pentyl-3-phenoxyazetidin-2-one: Selectively Targets Cancerous B Lymphocyte Mitochondria.
    Pirahmadi N; Zarghi A; Salimi A; Arefi H; Pourahmad J
    Anticancer Agents Med Chem; 2017; 17(9):1292-1301. PubMed ID: 28270082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine.
    Shanafelt TD; Lee YK; Bone ND; Strege AK; Narayanan VL; Sausville EA; Geyer SM; Kaufmann SH; Kay NE
    Blood; 2005 Mar; 105(5):2099-106. PubMed ID: 15388586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia.
    Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I
    Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
    Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
    Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria.
    Rotem R; Heyfets A; Fingrut O; Blickstein D; Shaklai M; Flescher E
    Cancer Res; 2005 Mar; 65(5):1984-93. PubMed ID: 15753398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia cells.
    Qiu LN; Zhou YL; Wang ZN; Huang Q; Hu WX
    Int J Oncol; 2012 Aug; 41(2):533-40. PubMed ID: 22581170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity Studies of the Crude venom and Fractions of Persian Gulf Snail (Conus textile) on Chronic Lymphocytic Leukemia and Normal Lymphocytes.
    Salimi A; Salehian S; Aboutorabi A; Vazirizadeh A; Adhami V; Sajjadi Alehashem SH; Seydi E; Pourahmad J
    Asian Pac J Cancer Prev; 2021 May; 22(5):1523-1529. PubMed ID: 34048181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
    Lucas DM; Edwards RB; Lozanski G; West DA; Shin JD; Vargo MA; Davis ME; Rozewski DM; Johnson AJ; Su BN; Goettl VM; Heerema NA; Lin TS; Lehman A; Zhang X; Jarjoura D; Newman DJ; Byrd JC; Kinghorn AD; Grever MR
    Blood; 2009 May; 113(19):4656-66. PubMed ID: 19190247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism.
    Trachootham D; Zhang H; Zhang W; Feng L; Du M; Zhou Y; Chen Z; Pelicano H; Plunkett W; Wierda WG; Keating MJ; Huang P
    Blood; 2008 Sep; 112(5):1912-22. PubMed ID: 18574029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
    Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
    Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance.
    Pramil E; Herbi Bastian L; Denèfle T; Nemati F; Xiao M; Lardé E; Maloum K; Roos-Weil D; Chapiro E; Le Garff-Tavernier M; Davi F; Decaudin D; Sarfati M; Nguyen-Khac F; Merle-Béral H; Karoyan P; Susin SA
    Blood Adv; 2019 Oct; 3(20):2920-2933. PubMed ID: 31648314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
    Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
    PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.